Systematic review and network meta-analysis of tedizolid for the treatment of acute bacterial skin and skin structure infections caused by MRSA

BACKGROUND: Tedizolid, the active moiety of tedizolid phosphate, is approved in the United States, the European Union, Canada and a number of other countries for the treatment of acute bacterial skin and skin structure infections (ABSSSI) caused by certain susceptible bacteria, including methicillin...

Descripción completa

Detalles Bibliográficos
Autores principales: McCool, Rachael, Gould, Ian M., Eales, Jacqui, Barata, Teresa, Arber, Mick, Fleetwood, Kelly, Glanville, Julie, Kauf, Teresa L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5219662/
https://www.ncbi.nlm.nih.gov/pubmed/28061827
http://dx.doi.org/10.1186/s12879-016-2100-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5219662/
https://www.ncbi.nlm.nih.gov/pubmed/28061827
http://dx.doi.org/10.1186/s12879-016-2100-3

Ejemplares similares